Wright Medical Group Buys Out Biotech International

Orthopedic company Wright Medical Group (NASDAQ: WMGI  ) has announced plans to acquire French orthopedic extremities company Biotech International for an offer of up to $80 million. The buyout transaction is expected to close in Q4 of 2013.

Upon closing the transaction, Biotech's operations are likely not to change significantly. Wright expects the merger will broaden its sales presence in the French foot and ankle product market. Biotech will also spin off its dental branch into its own company as a result of the acquisition.

Wright's president and chief executive officer, Robert Palmisano, says the company plans "to utilize Biotech's strong direct sales channel in France and established distributor presence in emerging markets to extend the reach of our international distribution network and further accelerate growth opportunities in our global Extremities business."

As of the market's close on October 16, Wright Medical's stock was trading at $27.42 per share. The company's stock has risen 30.6% since the start of 2013.

link


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2686914, ~/Articles/ArticleHandler.aspx, 4/23/2014 3:50:54 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement